Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hemoglobin--an obstetric risk factor]

L Heilmann1, B Hojnacki, B Herrle

  • 1Abt. Gynäkologie und Geburtshilfe Stadtkrankenhaus Rüsselsheim.

Geburtshilfe Und Frauenheilkunde
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histone and ribosomal RNA repetitive gene clusters of the boll weevil are linked in a tandem array.

Insect molecular biology·2010
Same author

The rheological changes after cesarean section: The influence of low molecular weight or unfractionated heparin on the rheological properties of blood.

Clinical hemorheology and microcirculation·2007
Same author

Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2006
Same author

[Influence of thrombophilia in women with recurrent miscarriage: pros and cons].

Hamostaseologie·2006
Same author

Fetal hemorheology in normal pregnancy and severe preeclampsia.

Clinical hemorheology and microcirculation·2005
Same author

[Hemostasis disorders in obstetrics and gynecology].

Hamostaseologie·2004
Same journal

Consensus on the Management of Inavolisib Side Effects. A Survey on Defined Side Effects, the Assumed Pathomechanism, Preventative and/or Therapeutic Measures Including the Integration of Additional Health Care Professionals - a Consensus Paper.

Geburtshilfe und Frauenheilkunde·2026
Same journal

Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025.

Geburtshilfe und Frauenheilkunde·2026
Same journal

Feasibility of <i>PIK3CA</i> Mutation Detection via Microfluidic Isolation of Disseminated Tumor Cells from Bone Marrow in Breast Cancer Patients.

Geburtshilfe und Frauenheilkunde·2026
Same journal

Stereotactic Vacuum-Assisted Biopsy in Photon-Counting Dedicated Spiral Breast CT: A Proof of Concept.

Geburtshilfe und Frauenheilkunde·2026
Same journal

RSV Prophylaxis in Neonates: Implementation and Parental Acceptance during the First RSV Season in Germany.

Geburtshilfe und Frauenheilkunde·2026
Same journal

Genital Herpes Simplex Virus (HSV) Infection During Pregnancy - Recommendations of the Working Group on Obstetrics and Prenatal Medicine (AGG - Section on Maternal Disorders).

Geburtshilfe und Frauenheilkunde·2026
See all related articles

High hemoglobin levels during pregnancy are linked to increased risks of preterm birth, growth issues, and newborn complications. This suggests higher blood viscosity may impair placental function.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Hematology

Context:

  • Investigated the association between maternal hemoglobin levels during the second trimester and pregnancy outcomes.
  • Utilized prospective study data including hemoglobin, blood pressure, proteinuria, and fetal cardiotocograms.
  • Examined perinatal morbidity in relation to maternal hematological status.

Purpose:

  • To explore the correlation between elevated second-trimester hemoglobin concentrations and adverse pregnancy outcomes.
  • To identify if high maternal hemoglobin is a risk factor for conditions like preterm birth, intrauterine growth retardation, and gestational hypertension.
  • To assess the link between high hemoglobin levels and specific neonatal morbidities such as respiratory distress syndrome and hyperviscosity.

Summary:

Related Experiment Videos

  • Women with hemoglobin levels >= 13 g/dl between 14-30 weeks gestation showed significantly higher rates of preterm birth (25%), intrauterine growth retardation (7.6%), gestational hypertension (31.5%), and low birth weight (10.3%).
  • High maternal hemoglobin was also associated with increased perinatal morbidity, including respiratory distress syndrome (9.3%) and newborn hyperviscosity (23.9%).
  • Findings support the hypothesis that increased blood viscosity or reduced hemodilution in pregnancy can lead to poor placental perfusion.

Impact:

  • Highlights the potential risks associated with elevated maternal hemoglobin during pregnancy.
  • Suggests that monitoring hemoglobin levels in the second trimester may aid in identifying pregnancies at higher risk for adverse outcomes.
  • Provides evidence for the role of blood viscosity in placental function and fetal well-being.